• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5

CATEGORIES

  • 10
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

4
4
7
21

PUBLISHED

0
0
2
21

PRODUCT TYPE

21

Search "Elan Corporation, plc - Product Pipeline Review - 2012" returned 21 results.

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012

Bipolar Disorder (Manic Depression) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012', provides an overview of the Bipolar...

August 2012
FROM

Demyelinating Diseases - Pipeline Review, H2 2012

Demyelinating Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Demyelinating Diseases - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

December 2012
FROM

Multiple Sclerosis - Pipeline Review, H2 2012

Multiple Sclerosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H2 2012', provides...

September 2012
FROM

Depression - Pipeline Review, H2 2012

Depression – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Depression - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2012
FROM

Neurodegenerative Diseases - Pipeline Review, H2 2012

Neurodegenerative Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neurodegenerative Diseases - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

September 2012
FROM

Neurology - Pipeline Review, H2 2012

Neurology – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neurology - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2012
FROM

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013

Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2013', provides an overview of the indication’s...

April 2013
FROM

Alzheimer's Disease - Pipeline Review, H2 2012

Alzheimer's Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H2 2012', provides an overview of the Alzheimer's Disease therapeutic pipeline....

August 2012
FROM

Primary Systemic Amyloidosis - Pipeline Review, H2 2012

Primary Systemic Amyloidosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

October 2012
FROM

Autoimmune Disorders - Pipeline Review, H2 2012

Autoimmune Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Autoimmune Disorders - Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline....

August 2012
FROM

Therapeutic Monoclonal Antibodies Markets

Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb)...

June 2009
FROM

Amyloidosis - Pipeline Review, H2 2012

Amyloidosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

September 2012
FROM

Alzheimer's Disease - Pipeline Review, H1 2012

Alzheimer's Disease – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Alzheimer's Disease - Pipeline Review, H1 2012', provides an overview of the Alzheimer's Disease therapeutic pipeline....

February 2012
FROM

Parkinson's Disease - Pipeline Review, H1 2012

Parkinson's Disease – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Parkinson's Disease - Pipeline Review, H1 2012', provides an overview of the Parkinson's Disease therapeutic pipeline....

January 2012
FROM

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

October 2011
FROM

Multiple Sclerosis - Pipeline Review, H1 2012

Multiple Sclerosis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H1 2012', provides an overview of the Multiple Sclerosis therapeutic pipeline....

February 2012
FROM

Parkinson's Disease - Pipeline Review, H2 2012

Parkinson's Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Parkinson's Disease - Pipeline Review, H2 2012', provides an overview of the Parkinson's Disease therapeutic pipeline....

July 2012
FROM
Nanotechnology in Drug Delivery - Global Strategic Business Report Nanotechnology in Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Nanotechnology in Drug Delivery - Global Strategic Business Report

This report analyzes the worldwide markets for Nanotechnology in Drug Delivery in US$ Million The Global Market is further analyzed by the following Drug Delivery Technologies: Nanocrystals, and Nanocarriers...

January 2014
FROM

Contract Manufacturing in Pharmaceutical Industry, 2015-2025

Amongst the increasing financial pressures and the need to reduce cost and improve efficiencies, the pharmaceutical industry has witnessed a paradigm shift from vertically integrated business model...

February 2015
FROM

Gene Therapy Partnering Terms and Agreements (3rd Edition)

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2014
FROM
Loading Indicator

Our Clients

Carrefour S.A. Dow Chemical Co Ltd. Motorola Solutions, Inc. Pfizer, Inc. Activision Publishing, Inc. 3M Company Estée Lauder Companies Inc.